About Gerhard Hagn
Gerhard Hagn is a chief executive officer and director at Ensho Therapeutics.
Experience
This experience comes from Gerhard Hagn's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gerhard Hagn in the role, so the role may have started earlier or lasted longer.
Ensho Therapeutics, Inc. Current
Chief Executive Officer and director
2026 – Present · Woodcliff Lake, NJ
Develops oral medicines for people with inflammatory diseases.
TB
Tourmaline Bio
Chief Commercial Officer (CCO) heading Commercial and Business Development
2023 – 2025
GS
Gilead Sciences
Vice President, Head of Inflammation, Liver & Portfolio, Global Commercial Strategy
2019 – 2023
PF
Pfizer
Vice President, Business Unit Lead, Inflammation & Immunology, Patient & Health Impact
1999 – 2019
Key Colleagues at Startups
The people Gerhard Hagn works with at each company, as listed on that company's latest Form D.
Ensho Therapeutics, Inc. · Form D, Oct 15, 2026
DF
Danielle Fry
Chief Operating Officer and Chief Legal Officer
AR
Arash Rassoulpour
Director
CS
Carlos Solorzano
Director
EP
Eric Pham
Director
NG
Neena Bitritto-Garg
Founder and Chief Executive Officer, director
TK
Tariq Kassum
Director